Agios Pharm Cash Flow-to-Debt Ratio
Agios Pharm cash flow-to-debt ratio. Agios Pharm (AGIO) has a Cash Flow-to-Debt Ratio of -0.70x as of June 2026, meaning its operating cash flow of $-57.31 Million could theoretically repay -1% of its total liabilities ($82.40 Million) in one year. Check Agios Pharm cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Agios Pharm (2011–2025)
Cash flow-to-debt ratio of Agios Pharm from 2011 to 2025. Historical debt coverage capacity for Agios Pharm across 15 annual periods. Check Agios Pharm (AGIO) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Agios Pharm Cash Flow-to-Debt Ratio by Year (2011–2025)
Agios Pharm cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Agios Pharm. For the full cash flow conversion analysis, see AGIO cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.58x | $-372.98 Million | $104.11 Million | ▼ -12.3% |
| 2024 | -3.19x | $-389.84 Million | $122.24 Million | ▼ -35.8% |
| 2023 | -2.35x | $-296.06 Million | $126.10 Million | ▼ -4.6% |
| 2022 | -2.24x | $-309.48 Million | $137.90 Million | ▲ +19.7% |
| 2021 | -2.79x | $-407.32 Million | $145.76 Million | ▼ -335.8% |
| 2020 | -0.64x | $-290.76 Million | $453.45 Million | ▲ +56.7% |
| 2019 | -1.48x | $-370.62 Million | $250.21 Million | ▲ +16.8% |
| 2018 | -1.78x | $-304.42 Million | $170.92 Million | ▼ -49.2% |
| 2017 | -1.19x | $-285.23 Million | $238.89 Million | ▼ -906.6% |
| 2016 | 0.15x | $38.56 Million | $260.50 Million | ▲ +114.4% |
| 2015 | -1.03x | $-76.95 Million | $74.95 Million | ▼ -16.8% |
| 2014 | -0.88x | $-59.35 Million | $67.54 Million | ▼ -8.6% |
| 2013 | -0.81x | $-56.40 Million | $69.72 Million | ▼ -52.0% |
| 2012 | -0.53x | $-49.55 Million | $93.11 Million | ▼ -359.2% |
| 2011 | -0.12x | $-15.22 Million | $131.33 Million | — |